These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 33675257)
1. A cell-penetrating CD40-TRAF2,3 blocking peptide diminishes inflammation and neuronal loss after ischemia/reperfusion. Portillo JC; Yu JS; Hansen S; Kern TS; Subauste MC; Subauste CS FASEB J; 2021 Mar; 35(3):e21412. PubMed ID: 33675257 [TBL] [Abstract][Full Text] [Related]
2. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells. Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892 [TBL] [Abstract][Full Text] [Related]
3. Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling. Portillo JA; Schwartz I; Zarini S; Bapputty R; Kern TS; Gubitosi-Klug RA; Murphy RC; Subauste MC; Subauste CS Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8590-7. PubMed ID: 25477319 [TBL] [Abstract][Full Text] [Related]
4. CD40 Upregulation in the Retina of Patients With Diabetic Retinopathy: Association With TRAF2/TRAF6 Upregulation and Inflammatory Molecule Expression. Vos S; Aaron R; Weng M; Daw J; Rodriguez-Rivera E; Subauste CS Invest Ophthalmol Vis Sci; 2023 Jun; 64(7):17. PubMed ID: 37294707 [TBL] [Abstract][Full Text] [Related]
5. Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells. Portillo JC; Yu JS; Vos S; Bapputty R; Lopez Corcino Y; Hubal A; Daw J; Arora S; Sun W; Lu ZR; Subauste CS Diabetologia; 2022 Dec; 65(12):2157-2171. PubMed ID: 35920844 [TBL] [Abstract][Full Text] [Related]
6. The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen. Ogolla PS; Portillo JA; White CL; Patel K; Lamb B; Sen GC; Subauste CS PLoS Pathog; 2013; 9(8):e1003557. PubMed ID: 23990781 [TBL] [Abstract][Full Text] [Related]
7. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes. Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947 [TBL] [Abstract][Full Text] [Related]
8. CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells. Greene JA; Portillo JA; Lopez Corcino Y; Subauste CS PLoS One; 2015; 10(12):e0144133. PubMed ID: 26710229 [TBL] [Abstract][Full Text] [Related]
9. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933 [TBL] [Abstract][Full Text] [Related]
10. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814 [TBL] [Abstract][Full Text] [Related]
11. CD40 Expressed in Endothelial Cells Promotes Upregulation of ICAM-1 But Not Pro-Inflammatory Cytokines, NOS2 and P2X7 in the Diabetic Retina. Yu JS; Daw J; Portillo JC; Subauste CS Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):22. PubMed ID: 34546322 [TBL] [Abstract][Full Text] [Related]
12. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Davies CC; Mak TW; Young LS; Eliopoulos AG Mol Cell Biol; 2005 Nov; 25(22):9806-19. PubMed ID: 16260598 [TBL] [Abstract][Full Text] [Related]
13. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Chatzigeorgiou A; Seijkens T; Zarzycka B; Engel D; Poggi M; van den Berg S; van den Berg S; Soehnlein O; Winkels H; Beckers L; Lievens D; Driessen A; Kusters P; Biessen E; Garcia-Martin R; Klotzsche-von Ameln A; Gijbels M; Noelle R; Boon L; Hackeng T; Schulte KM; Xu A; Vriend G; Nabuurs S; Chung KJ; Willems van Dijk K; Rensen PC; Gerdes N; de Winther M; Block NL; Schally AV; Weber C; Bornstein SR; Nicolaes G; Chavakis T; Lutgens E Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2686-91. PubMed ID: 24492375 [TBL] [Abstract][Full Text] [Related]
16. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Shen X; Wang Y; Gao F; Ren F; Busuttil RW; Kupiec-Weglinski JW; Zhai Y Hepatology; 2009 Nov; 50(5):1537-46. PubMed ID: 19670423 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation. Aarts SABM; Seijkens TTP; Kusters PJH; van der Pol SMA; Zarzycka B; Heijnen PDAM; Beckers L; den Toom M; Gijbels MJJ; Boon L; Weber C; de Vries HE; Nicolaes GAF; Dijkstra CD; Kooij G; Lutgens E J Neuroinflammation; 2017 May; 14(1):105. PubMed ID: 28494768 [TBL] [Abstract][Full Text] [Related]